BACKGROUND: Individuals with end-stage renal disease (ESRD) manifest a chronic inflammatory state. Serum albumin, C-reactive protein (CRP), interleukin-6 (IL-6) and serum amyloid A (SAA) have been associated with mortality in ESRD, although reports vary as to whether they are true independent markers of mortality. We undertook a prospective study to determine whether these markers could predict mortality in ESRD. METHODS: A cohort of individuals on haemodialysis was followed prospectively for a mean of 2.1 years. Albumin, CRP, IL-6 and SAA were drawn at enrollment. Association between mortality and serum markers was assessed using Cox proportional hazards regression. A trend analysis was undertaken to establish the functional form of the association between serum markers and outcome. RESULTS: After multivariable adjustment, IL-6 was most strongly associated with mortality, followed closely by albumin (P = 0.0002 and P = 0.0005, respectively). CRP was marginally associated with mortality (P = 0.046), and SAA was not independently associated with mortality. In the final model adjusting for the effects of both IL-6 and albumin simultaneously, both markers remained associated with mortality (P = 0.003 and P = 0.011). CONCLUSION: IL-6 had the strongest independent association with mortality, followed closely by albumin. CRP and SAA were not associated with mortality when measured at single time points. Increasing levels of IL-6 and decreasing levels of albumin were associated with increased mortality. IL-6 and albumin may be capturing different aspects of the inflammatory burden observed in haemodialysis patients.
BACKGROUND: Individuals with end-stage renal disease (ESRD) manifest a chronic inflammatory state. Serum albumin, C-reactive protein (CRP), interleukin-6 (IL-6) and serum amyloid A (SAA) have been associated with mortality in ESRD, although reports vary as to whether they are true independent markers of mortality. We undertook a prospective study to determine whether these markers could predict mortality in ESRD. METHODS: A cohort of individuals on haemodialysis was followed prospectively for a mean of 2.1 years. Albumin, CRP, IL-6 and SAA were drawn at enrollment. Association between mortality and serum markers was assessed using Cox proportional hazards regression. A trend analysis was undertaken to establish the functional form of the association between serum markers and outcome. RESULTS: After multivariable adjustment, IL-6 was most strongly associated with mortality, followed closely by albumin (P = 0.0002 and P = 0.0005, respectively). CRP was marginally associated with mortality (P = 0.046), and SAA was not independently associated with mortality. In the final model adjusting for the effects of both IL-6 and albumin simultaneously, both markers remained associated with mortality (P = 0.003 and P = 0.011). CONCLUSION:IL-6 had the strongest independent association with mortality, followed closely by albumin. CRP and SAA were not associated with mortality when measured at single time points. Increasing levels of IL-6 and decreasing levels of albumin were associated with increased mortality. IL-6 and albumin may be capturing different aspects of the inflammatory burden observed in haemodialysis patients.
Authors: Paul L Kimmel; Lakhmir S Chawla; Amali Amarasinghe; Rolf A Peterson; Karen L Weihs; Samuel J Simmens; Sylvan Alleyne; Harry B Burke; Illuminado Cruz; Judith H Veis Journal: Nephrol Dial Transplant Date: 2003-02 Impact factor: 5.992
Authors: Madhumathi Rao; Daqing Guo; Mary C Perianayagam; Hocine Tighiouart; Bertrand L Jaber; Brian J G Pereira; Vaidyanathapuram S Balakrishnan Journal: Am J Kidney Dis Date: 2005-02 Impact factor: 8.860
Authors: Y Wang; J Ripperger; G H Fey; D Samols; T Kordula; M Wetzler; R A Van Etten; H Baumann Journal: Hepatology Date: 1999-09 Impact factor: 17.425
Authors: George A Kaysen; Tom Greene; John T Daugirdas; Paul L Kimmel; Gerald W Schulman; Robert D Toto; Nathan W Levin; Guofen Yan Journal: Am J Kidney Dis Date: 2003-12 Impact factor: 8.860
Authors: João L Viana; George C Kosmadakis; Emma L Watson; Alan Bevington; John Feehally; Nicolette C Bishop; Alice C Smith Journal: J Am Soc Nephrol Date: 2014-04-03 Impact factor: 10.121
Authors: Allan R Tenorio; Yu Zheng; Ronald J Bosch; Supriya Krishnan; Benigno Rodriguez; Peter W Hunt; Jill Plants; Arjun Seth; Cara C Wilson; Steven G Deeks; Michael M Lederman; Alan L Landay Journal: J Infect Dis Date: 2014-05-01 Impact factor: 5.226
Authors: Christine E Haugen; Alden Gross; Nadia M Chu; Silas P Norman; Daniel C Brennan; Qian-Li Xue; Jeremy Walston; Dorry L Segev; Mara McAdams-DeMarco Journal: J Gerontol A Biol Sci Med Sci Date: 2021-02-25 Impact factor: 6.053
Authors: Tariq Shafi; Bernard G Jaar; Laura C Plantinga; Nancy E Fink; John H Sadler; Rulan S Parekh; Neil R Powe; Josef Coresh Journal: Am J Kidney Dis Date: 2010-06-03 Impact factor: 8.860
Authors: Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash Journal: J Neuroinflammation Date: 2010-03-11 Impact factor: 8.322
Authors: Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin Journal: Clin Rev Allergy Immunol Date: 2010-04 Impact factor: 8.667
Authors: Stanislas Werfel; Georg Lorenz; Bernhard Haller; Roman Günthner; Julia Matschkal; Matthias C Braunisch; Carolin Schaller; Peter Gundel; Stephan Kemmner; Salim S Hayek; Christian Nusshag; Jochen Reiser; Philipp Moog; Uwe Heemann; Christoph Schmaderer Journal: Sci Rep Date: 2021-04-29 Impact factor: 4.379